Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 51 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 56 | 2,193−7.1%/yr | −7.1%/yr | 3.41.1× | 5% | 2,190 in 20300%/yr |
| Lumbar fusion | 51 | 1,950−5.1%/yr | −5.1%/yr | 3.01.1× | 0% | 2,150 in 2030+1.6%/yr |
| Kyphoplasty & vertebroplasty | 13 | 1,235−7.5%/yr | −7.5%/yr | 2.01.5× | 5% | 1,060 in 2030−2.5%/yr |
| Cervical fusion & disc arthroplasty | 25 | 1,166−5.8%/yr | −5.8%/yr | 1.81.4× | 1% | 1,250 in 2030+1.1%/yr |
| SI joint fusion | 3 | 175−4%/yr | −4%/yr | 0.31.3× | 40% | 760 in 2030+28%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 245 | 52,294−2.9%/yr | −2.9%/yr | 80.21.0× | 23% | 55,400 in 2030+1%/yr |
| Skin substitutes & wound grafts | 32 | 8,053+4.4%/yr | +4.4%/yr | 7.71.0× | 47% | 8,660 in 2030+1.2%/yr |
| Bone graft & orthobiologics | 9 | 352−20%/yr | −20%/yr | 0.50.8× | 2% | 330 in 2030−1.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 93 | 6,170+1.6%/yr | +1.6%/yr | 9.51.1× | 28% | 8,640 in 2030+5.8%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 16 | 810+4.4%/yr | +4.4%/yr | 1.21.1× | 32% | 1,190 in 2030+6.6%/yr |
| Spinal cord & DRG stimulation | 21 | 634−4.8%/yr | −4.8%/yr | 0.91.4× | 41% | 660 in 2030+0.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 19 | 2,750−14%/yr | −14%/yr | 4.21.0× | 21% | 3,390 in 2030+3.5%/yr |
| Dialysis access | 31 | 2,606−17%/yr | −17%/yr | 4.40.9× | 32% | 2,570 in 2030−0.2%/yr |
| Superficial venous ablation | 28 | 2,393−9.5%/yr | −9.5%/yr | 3.71.1× | 75% | 2,400 in 2030+0.1%/yr |
| Carotid revascularization | 24 | 999−5.5%/yr | −5.5%/yr | 1.61.4× | 0% | 1,110 in 2030+1.7%/yr |
| Thrombectomy, IVC filters & venous stents | 8 | 855−5.5%/yr | −5.5%/yr | 1.41.0× | 0% | 790 in 2030−1.3%/yr |
| Aortic endografts (EVAR/TEVAR) | 5 | 372−9.1%/yr | −9.1%/yr | 0.61.3× | 0% | 340 in 2030−1.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 51 | 4,103−3.2%/yr | −3.2%/yr | 7.01.2× | 3% | 5,000 in 2030+3.4%/yr |
| Cholecystectomy & appendectomy | 76 | 3,242−6.5%/yr | −6.5%/yr | 5.41.3× | 2% | 3,240 in 20300%/yr |
| Colorectal resection | 6 | 1,232−5.9%/yr | −5.9%/yr | 2.01.2× | 0% | 1,250 in 2030+0.2%/yr |
| Antireflux & hiatal hernia surgery | 13 | 810+0.3%/yr | +0.3%/yr | 1.31.8× | 0% | 810 in 2030+0.1%/yr |
| Breast reconstruction | 1 | 273−7.1%/yr | −7.1%/yr | 0.41.1× | 0% | 200 in 2030−4.9%/yr |
| Bariatric surgery | 2 | 199−20%/yr | −20%/yr | 0.31.7× | 0% | 170 in 2030−2.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 83 | 3,766−2.6%/yr | −2.6%/yr | 6.11.1× | 19% | 4,330 in 2030+2.4%/yr |
| BPH procedures | 44 | 2,933−12%/yr | −12%/yr | 4.71.0× | 20% | 2,710 in 2030−1.3%/yr |
| Hysterectomy, hysteroscopy & ablation | 13 | 1,625−3.4%/yr | −3.4%/yr | 2.91.0× | 10% | 1,650 in 2030+0.2%/yr |
| Incontinence, prolapse & sacral neuromodulation | 21 | 1,596−2.3%/yr | −2.3%/yr | 2.61.2× | 10% | 1,480 in 2030−1.2%/yr |
| Prostatectomy & nephrectomy | 11 | 798−1.8%/yr | −1.8%/yr | 1.41.0× | 0% | 980 in 2030+3.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 24 | 2,268−7.2%/yr | −7.2%/yr | 3.71.0× | 88% | 2,500 in 2030+1.7%/yr |
| Sleep apnea & airway implants | 11 | 224+173%/yr | +173%/yr | 0.31.8× | 0% | 150 in 2030−6.1%/yr |
| Ear tubes & middle ear surgery | 1 | 134−17%/yr | −17%/yr | 0.20.6× | 0% | 240 in 2030+10%/yr |
| Cochlear implants | 4 | 129−5.7%/yr | −5.7%/yr | 0.21.1× | 0% | 130 in 2030−0.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 83 | 5,112−2.1%/yr | −2.1%/yr | 8.81.2× | 2% | 5,760 in 2030+2%/yr |
| Tumor & fibroid embolization | 6 | 541+7.4%/yr | +7.4%/yr | 0.91.8× | 56% | 860 in 2030+8.1%/yr |
| Tumor ablation | 1 | 251−2.1%/yr | −2.1%/yr | 0.41.3× | 0% | 510 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 161 | 21,566+29%/yr | +29%/yr | 34.11.3× | 80% | 38,800 in 2030+10%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 69 | 3,704−3.1%/yr | −3.1%/yr | 6.21.2× | 1% | 3,900 in 2030+0.9%/yr |
| LAA occlusion & loop recorders | 58 | 2,381+6.1%/yr | +6.1%/yr | 3.31.1× | 1% | 3,950 in 2030+8.8%/yr |
| EP ablation | 37 | 1,982+3.6%/yr | +3.6%/yr | 2.70.8× | 0% | 3,810 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 136 | 5,507−8.8%/yr | −8.8%/yr | 7.21.2× | 0% | 5,950 in 2030+1.3%/yr |
| Structural heart (TAVR, TEER) | 69 | 1,246+3.7%/yr | +3.7%/yr | 1.70.9× | 0% | 1,610 in 2030+4.4%/yr |
| Mechanical circulatory support | 2 | 453−5.2%/yr | −5.2%/yr | 0.71.2× | 0% | 390 in 2030−2.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Stroke thrombectomy | 12 | 310+5.1%/yr | +5.1%/yr | 0.51.3× | 0% | 380 in 2030+3.2%/yr |
| Aneurysm & intracranial embolization | 6 | 309+17%/yr | +17%/yr | 0.51.2× | 0% | 370 in 2030+2.8%/yr |
| DBS & VNS | 3 | 276−9.1%/yr | −9.1%/yr | 0.41.3× | 0% | 290 in 2030+0.5%/yr |
| CSF shunts | 0 | 137−5.5%/yr | −5.5%/yr | 0.21.2× | 0% | 180 in 2030+4.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 163 | 35,677−3.1%/yr | −3.1%/yr | 56.50.8× | 81% | 35,000 in 2030−0.3%/yr |
| Vitreoretinal surgery | 35 | 1,908−0.3%/yr | −0.3%/yr | 3.11.3× | 51% | 1,740 in 2030−1.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 371 | 72,989−5%/yr | −5%/yr | 122.51.1× | 27% | 74,000 in 2030+0.2%/yr |
| ERCP & endoscopic ultrasound | 46 | 4,278−2.6%/yr | −2.6%/yr | 7.11.9× | 2% | 4,480 in 2030+0.8%/yr |
| Bronchoscopy & lung nodule | 36 | 2,414−2.3%/yr | −2.3%/yr | 3.91.1× | 2% | 2,900 in 2030+3.1%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.